Patents by Inventor Karamjit Jandu

Karamjit Jandu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220220122
    Abstract: The invention relates to novel heteroaryl compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cardiovascular diseases, and methods treating sepsis or septic shock, using the novel heterocyclic compounds disclosed herein.
    Type: Application
    Filed: December 20, 2021
    Publication date: July 14, 2022
    Inventors: Michael H. SERRANO-WU, Mark CHAMBERS, Erica GOLDSMITH, Jason TIERNEY, Karamjit JANDU, David CLARK, Paul HINCHLIFFE
  • Patent number: 11248001
    Abstract: The invention relates to novel heteroaryl compounds of Formula (I) and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cardiovascular diseases, and methods treating sepsis or septic shock, using the novel heterocyclic compounds disclosed herein.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: February 15, 2022
    Assignee: AstraZeneca AB
    Inventors: Michael H. Serrano-Wu, Mark Chambers, Erica Goldsmith, Jason Tierney, Karamjit Jandu, David Clark, Paul Hinchliffe
  • Publication number: 20200291041
    Abstract: The invention relates to novel heteroaryl compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cardiovascular diseases, and methods treating sepsis or septic shock, using the novel heterocyclic compounds disclosed herein.
    Type: Application
    Filed: January 16, 2020
    Publication date: September 17, 2020
    Inventors: Michael H. Serrano-Wu, Mark Chambers, Erica Goldsmith, Jason Tierney, Karamjit Jandu, David Clark, Paul Hinchliffe
  • Publication number: 20070129367
    Abstract: The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
    Type: Application
    Filed: September 25, 2003
    Publication date: June 7, 2007
    Inventors: Andrew Eatherton, Gerard Giblin, Richard Green, Jennifer Doughty, Karamjit Jandu, William Mitchell, Alan Naylor, Giovanni Palombi, Derek Rawlings, Brian Slingsby, Andrew Whittington
  • Publication number: 20060240048
    Abstract: The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
    Type: Application
    Filed: September 25, 2003
    Publication date: October 26, 2006
    Inventors: Andrew Eatherton, Gerard Martin Giblin, Richard Green, Jennifer Doughty, Karamjit Jandu, William Mitchell, Alan Naylor, Giovanni Palombi, Derek Rawlings, Brian Slingsby, Andrew Whittington